Suchergebnisse - "de Wit, H M"

PubPharm (6)

1

A cost-controlling treatment strategy of adding liraglutide to insulin in type 2 diabetes

enthalten in: The Netherlands journal of medicine | 2017

von de Wit, H. | Vervoort, G. | de Galan, B. | +1

2

Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain : 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized controlled trial

enthalten in: Journal of internal medicine | 2016

von de Wit, H. | Vervoort, G. | Jansen, H. | +2

3

Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized control

enthalten in: Journal of internal medicine / Supplement | 2016

von de Wit, H. | Vervoort, G. | Jansen, H. | +2

4

Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes

enthalten in: Diabetes, obesity & metabolism | 2015

von de Wit, H. | Engwerda, E. | Tack, C. | +1

5

MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level

enthalten in: The Netherlands journal of medicine | 2012

von de Wit, H. | Westeneng, H. | van Engelen, B. | +1

6

Endothelial function in familial combined hyperlipidaemia

enthalten in: European journal of clinical investigation | 2007

von Ter Avest, E. | Holewijn, S. | van Tits, L. | +3

1
[1]